Ayal Ronen, Senior Director, Marketing & Sales, FreeMind Group
In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies. The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation. In this webinar we will present the latest trends at the NIH and the new available funding opportunities with respect to medical devices.
In this webinar we will discuss:
• Trends in medical device non-dilutive funding
• Cross section analysis of different opportunities available
• The NIBIB – The national institute of Biomedical Imaging and Bioengineering
• How to maximize chances for success
Tuesday, August 30th at 1:00-1:30 PM EDT
The webinar is designed for experienced companies and researches from the academia, as well as for first-time submitters who wish to increase their chances for award, as well as the total amount of funding awarded.
The webinar is FREE of charge.
To register, please contact Hannah Rosencweig at (617) 648-0340, ext. 220, or at Hannah@freemindconsultants.com
FreeMind is a consultancy firm that specializes in raising funds from government agencies and other non-dilutive sources through grants and contracts. Over the past decade we have helped hundreds of companies and academic institutions to secure government funding, mainly from the NIH and DOD. The enhanced joint process of our 25 full-time analysts and writers supports our clients’ needs, from the strategic assessment of the research objectives to writing the applications.